- Home
- RGC vs BRKR Comparison
RGC vs BRKR Comparison
Compare RGC & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RGC | BRKR |
|---|---|---|
| Founded | 2014 | 1960 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.4B | 7.0B |
| IPO Year | 2021 | 2000 |
Fundamental Metrics
Financial Performance| Metric | RGC | BRKR |
|---|---|---|
| Price | $17.59 | $45.15 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 12 |
| Target Price | N/A | ★ $46.45 |
| AVG Volume (30 Days) | 210.3K | ★ 2.4M |
| Earning Date | 10-24-2025 | 11-03-2025 |
| Dividend Yield | N/A | ★ 0.44% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,438,900,000.00 |
| Revenue This Year | N/A | $3.61 |
| Revenue Next Year | N/A | $1.23 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 6.10 |
| 52 Week Low | $0.09 | $28.53 |
| 52 Week High | $83.60 | $64.64 |
Technical Indicators
Market Signals| Indicator | RGC | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 64.34 | 51.48 |
| Support Level | $16.10 | $44.96 |
| Resistance Level | $17.40 | $47.88 |
| Average True Range (ATR) | 1.62 | 1.82 |
| MACD | 0.63 | -0.55 |
| Stochastic Oscillator | 88.24 | 2.89 |
Price Performance
Historical ComparisonAbout RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.